Evergreen Capital Management LLC Allogene Therapeutics, Inc. Transaction History

Evergreen Capital Management LLC

  • $2.6 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Mar 11, 2022
SELL
$13.13 - $24.52 $123,422 - $230,488
-9,400 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$32.38 - $44.96 $1.3 Million - $1.81 Million
-40,236 Reduced 81.06%
9,400 $354,000
Q2 2020

Aug 14, 2020
BUY
$18.39 - $54.04 $912,806 - $2.68 Million
49,636 New
49,636 $2.13 Million

Others Institutions Holding ALLO

# of Institutions
176
Shares Held
132M
Call Options Held
94.3K
Put Options Held
112K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $403M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email